8 active trials 6 recruiting 6 Phase 3 3 disease areas 7 changes in 30 days
5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.
Primary and study completion pushed from Jun 2028 to Jun 2030
Also in this update: Enrollment increased: 256 → 786 participants
Alkermes, Inc.Phase 2/3 NCT06767683 Registry history of NCT06767683 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment closed, study ongoing
Alkermes, Inc.Phase 2 NCT06843590 Registry history of NCT06843590 on ClinicalTrials.gov (opens the registry)
Updated
Trial sites expanded: 17 → 20 locations
Alkermes, Inc.Phase 3 NCT07540897 Registry history of NCT07540897 on ClinicalTrials.gov (opens the registry)
Updated
Trial sites expanded: 38 → 44 locations
Alkermes, Inc.Phase 3 NCT07502443 Registry history of NCT07502443 on ClinicalTrials.gov (opens the registry)
Updated
Trial sites expanded: 2 → 19 locations
Alkermes, Inc.Phase 2 NCT07755410 Registry history of NCT07755410 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 2 | 2 | |
| Phase 2/3 | 1 | |
| Phase 3 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07455383 | A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 | Narcolepsy Type 1 | Recruiting | 2026-10-07 |
| NCT07502443 | A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 | Narcolepsy Type 2 | Recruiting | 2026-10-07 |
| NCT07540897 | A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With… | Narcolepsy Type 1 | Recruiting | 2026-10-07 |
| NCT05303064 | Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects… | Schizophrenia | Recruiting | 2026-08-14 |
| NCT04987229 | Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects | Bipolar I Disorder | Enrolling by Invitation | 2026-08-14 |
| Phase 2/3 | ||||
| NCT06767683 | A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia | Narcolepsy Type 1 | Recruiting | 2026-10-09 |
| Phase 2 | ||||
| NCT07755410 | A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult… | Attention Deficit Disorder With Hyperactivity (ADHD) | Recruiting | 2026-10-07 |
| NCT06843590 | A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic… | Idiopathic Hypersomnia | Active, Not Recruiting | 2026-09-25 |
Bipolar Disorder (2) · Schizophrenia (2) · ADHD (1)